{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:55:37Z","timestamp":1787316937256,"version":"build-2736575974"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["AR-757\/1\u20131"],"award-info":[{"award-number":["AR-757\/1\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To fully understand why C-reactive protein (CRP) is usually only mildly elevated in active systemic lupus erythematosus (SLE), although interleukin-6 (IL-6) is increased, but is high in SLE patients with bacterial infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sera and peripheral blood mononuclear cells (PBMCs) of SLE patients and healthy individuals were investigated. IL-6 and soluble IL-6 receptor (sIL-6R) were measured by ELISA. Membrane IL-6 receptor-\u03b1 (CD126), gp130 (CD130) and signal transducer and activator of transcription 3 (STAT3) phosphorylation after IL-6 stimulation were analysed by flow cytometry. PBMCs and HepG2 liver cells were stimulated with various cytokines, and IL-6 receptor shedding was determined by immunoprecipitation and western blotting of supernatants. HEK-293 T cells were transfected with wild type CD126 or a shedding-resistant mutant, and soluble sIL-6R was measured following cytokine stimulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>While sIL-6R and IL-6 were increased with SLE activity, CD126 positive lymphocytes were decreased in SLE. IL-6 plus IFN\u03b1 decreased CD126 on lymphocytes, but increased sIL-6R in their supernatant, detected by immunoprecipitation and western blotting. IL-6 plus IFN\u03b1 on HepG2 liver cells resulted in a similar sIL-6R increase. Increased supernatant sIL-6R was seen in HEK-293 T cells transfected with wild type CD126, but not those transfected with the shedding-resistant mutant. STAT3 phosphorylation upon IL-6 stimulation was reduced.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The combination of IL-6 and type I IFN induces shedding of CD126 to sIL-6R, shifting IL-6 signalling to trans-signalling. In situations of IL-6 excess over sIL-6R only, IL-6 or IL-6\u2013sIL-6R complexes reach the liver and increase CRP. These findings not only explain the discrepancy in SLE, but also have implications for severe viral infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf281","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T16:01:34Z","timestamp":1752076894000},"page":"5793-5802","source":"Crossref","is-referenced-by-count":4,"title":["Type I interferon limits interleukin-6 signalling in SLE through shedding interleukin-6 receptors"],"prefix":"10.1093","volume":"64","author":[{"given":"Martyna","family":"Hempel","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine III, and interdisciplinary University Center for Autoimmune and Rheumatic Entities (UCARE), University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden , Dresden,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Klapproth","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine Carl Gustav Carus at the TU Dresden , Dresden,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Krause","sequence":"additional","affiliation":[{"name":"Institute of Musculoskeletal Medicine, University Hospital M\u00fcnster , M\u00fcnster,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Becker-Pauly","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry, University of Kiel , Kiel,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zeissig","sequence":"additional","affiliation":[{"name":"Department of Medicine I, and interdisciplinary University Center for Autoimmune and Rheumatic Entities (UCARE), University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden , Dresden,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babett","family":"Heschel","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine III, and interdisciplinary University Center for Autoimmune and Rheumatic Entities (UCARE), University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden , Dresden,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Weser","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine Carl Gustav Carus at the TU Dresden , Dresden,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Fantana","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine III, and interdisciplinary University Center for Autoimmune and Rheumatic Entities (UCARE), University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden , Dresden,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai","family":"Leuchten","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine III, and interdisciplinary University Center for Autoimmune and Rheumatic Entities (UCARE), University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden , Dresden,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rose-John","sequence":"additional","affiliation":[{"name":"Department of Medicine I, and interdisciplinary University Center for Autoimmune and Rheumatic Entities (UCARE), University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden , Dresden,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"El-Armouche","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine Carl Gustav Carus at the TU Dresden , Dresden,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelheid","family":"Korb-Pap","sequence":"additional","affiliation":[{"name":"Institute of Musculoskeletal Medicine, University Hospital M\u00fcnster , M\u00fcnster,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4471-8375","authenticated-orcid":false,"given":"Martin","family":"Aringer","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine III, and interdisciplinary University Center for Autoimmune and Rheumatic Entities (UCARE), University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden , Dresden,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"2025110820504043400_keaf281-B1","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease","volume":"112","author":"Nishimoto","year":"2008","journal-title":"Blood"},{"key":"2025110820504043400_keaf281-B2","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.4049\/jimmunol.160.11.5294","article-title":"Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice","volume":"160","author":"Szalai","year":"1998","journal-title":"J Immunol"},{"key":"2025110820504043400_keaf281-B3","doi-asserted-by":"crossref","first-page":"102374","DOI":"10.1016\/j.jaut.2019.102374","article-title":"Inflammatory markers in systemic lupus erythematosus","volume":"110","author":"Aringer","year":"2020","journal-title":"J Autoimmun"},{"key":"2025110820504043400_keaf281-B4","first-page":"565","article-title":"Cytokine production, serum levels and disease activity in systemic lupus erythematosus","volume":"18","author":"Grondal","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"2025110820504043400_keaf281-B5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1089\/jir.2018.0169","article-title":"Changes of serum IL-6, IL-17, and complements in systemic lupus erythematosus patients","volume":"39","author":"Tang","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"2025110820504043400_keaf281-B6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/rheumatology\/35.11.1067","article-title":"Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus","volume":"35","author":"Studnicka-Benke","year":"1996","journal-title":"Br J Rheumatol"},{"key":"2025110820504043400_keaf281-B7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s100670050045","article-title":"Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus","volume":"18","author":"Davas","year":"1999","journal-title":"Clin Rheumatol"},{"key":"2025110820504043400_keaf281-B8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2249.1992.tb05840.x","article-title":"Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?","volume":"90","author":"Spronk","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"2025110820504043400_keaf281-B9","first-page":"815","article-title":"Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis","volume":"20","author":"Gabay","year":"1993","journal-title":"J Rheumatol"},{"key":"2025110820504043400_keaf281-B10","first-page":"17","article-title":"Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders","volume":"13","author":"Stuart","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"2025110820504043400_keaf281-B11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF02238963","article-title":"Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins","volume":"16","author":"Lacki","year":"1997","journal-title":"Clin Rheumatol"},{"key":"2025110820504043400_keaf281-B12","first-page":"454","article-title":"Studies of serum C-reactive protein in systemic lupus erythematosus","volume":"32","author":"Williams","year":"2005","journal-title":"J Rheumatol"},{"key":"2025110820504043400_keaf281-B13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clim.2005.11.006","article-title":"Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6","volume":"119","author":"Suh","year":"2006","journal-title":"Clin Immunol"},{"key":"2025110820504043400_keaf281-B14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0961203310393378","article-title":"High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus","volume":"20","author":"Firooz","year":"2011","journal-title":"Lupus"},{"key":"2025110820504043400_keaf281-B15","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/ar1032","article-title":"Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus","volume":"6","author":"Sjowall","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"2025110820504043400_keaf281-B16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/ard.2005.037895","article-title":"Antibodies to C reactive protein","volume":"65","author":"Rosenau","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2025110820504043400_keaf281-B17","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/art.38408","article-title":"Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-alpha and a C-reactive protein gene variant","volume":"66","author":"Enocsson","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025110820504043400_keaf281-B18","doi-asserted-by":"crossref","first-page":"622326","DOI":"10.3389\/fimmu.2020.622326","article-title":"C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205","volume":"11","author":"Enocsson","year":"2020","journal-title":"Front Immunol"},{"key":"2025110820504043400_keaf281-B19","doi-asserted-by":"crossref","first-page":"e0289012","DOI":"10.1371\/journal.pone.0289012","article-title":"Evaluation of CRP as a marker for bacterial infection and malaria in febrile children at the Douala Gyneco-Obstetric and Pediatric Hospital","volume":"18","author":"Ngwengi","year":"2023","journal-title":"PLoS One"},{"key":"2025110820504043400_keaf281-B20","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1186\/ar565","article-title":"The paradigm of IL-6: from basic science to medicine","volume":"4(Suppl 3)","author":"Naka","year":"2002","journal-title":"Arthritis Res"},{"key":"2025110820504043400_keaf281-B21","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41577-023-00856-y","article-title":"Targeting IL-6 trans-signalling: past, present and future prospects","volume":"23","author":"Rose-John","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"2025110820504043400_keaf281-B22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/rheumatology\/kep329","article-title":"Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor","volume":"49","author":"Dayer","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2025110820504043400_keaf281-B23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1440-1746.2001.02588.x","article-title":"Expression of interleukin-6, leukemia inhibitory factor and their receptors by colonic epithelium and pericryptal fibroblasts","volume":"16","author":"Rockman","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"2025110820504043400_keaf281-B24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/75068","article-title":"Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo","volume":"6","author":"Atreya","year":"2000","journal-title":"Nat Med"},{"key":"2025110820504043400_keaf281-B25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1074-7613(04)00003-2","article-title":"IL-6 trans-signaling: the heat is on","volume":"20","author":"Rose-John","year":"2004","journal-title":"Immunity"},{"key":"2025110820504043400_keaf281-B26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.beem.2015.07.001","article-title":"The soluble interleukin-6 receptor and related proteins","volume":"29","author":"Rose-John","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2025110820504043400_keaf281-B27","doi-asserted-by":"crossref","first-page":"26059","DOI":"10.1074\/jbc.M115.649509","article-title":"Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles","volume":"290","author":"Schumacher","year":"2015","journal-title":"J Biol Chem"},{"key":"2025110820504043400_keaf281-B28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/eji.1830230226","article-title":"The soluble interleukin-6 receptor is generated by shedding","volume":"23","author":"Mullberg","year":"1993","journal-title":"Eur J Immunol"},{"key":"2025110820504043400_keaf281-B29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-023-00596-6","article-title":"The Alzheimer\u2019s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130","volume":"18","author":"M\u00fcller","year":"2023","journal-title":"Mol Neurodegener"},{"key":"2025110820504043400_keaf281-B30","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2025110820504043400_keaf281-B31","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2025110820504043400_keaf281-B32","first-page":"549","article-title":"Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE","volume":"10","author":"Bencivelli","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"2025110820504043400_keaf281-B33","doi-asserted-by":"crossref","first-page":"44053","DOI":"10.1038\/srep44053","article-title":"Meprin metalloproteases generate biologically active soluble interleukin-6 receptor to induce trans-signaling","volume":"7","author":"Arnold","year":"2017","journal-title":"Sci Rep"},{"key":"2025110820504043400_keaf281-B34","doi-asserted-by":"crossref","first-page":"14756","DOI":"10.1074\/jbc.M113.466169","article-title":"Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling","volume":"288","author":"Baran","year":"2013","journal-title":"J Biol Chem"},{"key":"2025110820504043400_keaf281-B35","doi-asserted-by":"crossref","first-page":"E411","DOI":"10.1152\/ajpendo.00166.2019","article-title":"The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes","volume":"317","author":"Aparicio-Siegmund","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2025110820504043400_keaf281-B36","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1152\/japplphysiol.00520.2022","article-title":"Acute interleukin-6 modulates key enzymes involved in prefrontal cortex and hippocampal amyloid precursor protein processing","volume":"134","author":"Marko","year":"2023","journal-title":"J Appl Physiol"},{"key":"2025110820504043400_keaf281-B37","doi-asserted-by":"crossref","first-page":"e0120274","DOI":"10.1371\/journal.pone.0120274","article-title":"Soluble interleukin-15 complexes are generated in vivo by type I interferon dependent and independent pathways","volume":"10","author":"Anthony","year":"2015","journal-title":"PLoS One"},{"key":"2025110820504043400_keaf281-B38","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025110820504043400_keaf281-B39","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2025110820504043400_keaf281-B40","first-page":"1473","article-title":"A bridge between interferon-alpha and tumor necrosis factor in lupus","volume":"35","author":"Aringer","year":"2008","journal-title":"J Rheumatol"},{"key":"2025110820504043400_keaf281-B41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1440-1711.2002.01112.x","article-title":"The interplay of dendritic cell subsets in systemic lupus erythematosus","volume":"80","author":"Palucka","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"2025110820504043400_keaf281-B42","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1038\/s41467-020-19918-z","article-title":"Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity","volume":"11","author":"Psarras","year":"2020","journal-title":"Nature communications"},{"key":"2025110820504043400_keaf281-B43","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1002\/art.25042","article-title":"Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares?","volume":"60","author":"Enocsson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2025110820504043400_keaf281-B44","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/0961203315585815","article-title":"Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus","volume":"24","author":"Cai","year":"2015","journal-title":"Lupus"},{"key":"2025110820504043400_keaf281-B45","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/hep.30774","article-title":"IL-6 Trans-signaling Controls Liver Regeneration After Partial Hepatectomy","volume":"70","author":"Fazel Modares","year":"2019","journal-title":"Hepatology"},{"key":"2025110820504043400_keaf281-B46","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002525","article-title":"Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature","volume":"8","author":"Karonitsch","year":"2022","journal-title":"RMD Open"},{"key":"2025110820504043400_keaf281-B47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00001432-200106000-00007","article-title":"The role of C-reactive protein in the resolution of bacterial infection","volume":"14","author":"Du Clos","year":"2001","journal-title":"Curr Opin Infect Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf281\/63713328\/keaf281.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/11\/5793\/63713328\/keaf281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/11\/5793\/63713328\/keaf281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:50:51Z","timestamp":1762653051000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/11\/5793\/8195742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,7,9]]},"published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf281","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,7,9]]}}}